Lastly, activation of TGF‐β1 and SMAD signaling pathways by NEAT1 shRNA was inhibited when miR‐495‐3p mimics was added to HUVECs treated with BS patient serum (Figure 4E,F). The gene discussed is TGFB1; the disease is Bloom syndrome.